IDT Biologika is a global Contract Development and Manufacturing Organization for Innovative Vaccines, Cell & Gene Therapeutics and Aseptic Fill-Finish of other biologics.

The company combines an more than 100-year-old tradition in vaccine research and production with maximum expertise and state-of-the-art technology.

We offer clients a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes Process Development, Drug Substance Manufacturing, Sterile Dosage Fill-Finish, Labelling & Packaging, Quality Control & Analytics.

IDT Biologika handles every step in manufacturing and packaging of small clinical batches and large scale commercial products. 

At its headquarters in Germany, IDT Biologika operates one of Europe’s premiere integrated facilities for end-to-end services from process development through clinical phases I-III to commercial manufacturing.

In Rockville, MA, USA we utilize broad capabilities and a depth of technologies for process development and manufacturing of clinical trial material for vaccines and cell&gene therapeutics for phases I-II.

Our fully integrated services are underscored by our commitment to quality and operational excellence that flows through our best-in-class process and cGMP (up to BSL2) manufacturing capabilities meeting FDA, EMA and ANVISA standards. 

We supply our client’s products in vials, pre-filled syringes (with and without safety devices), autoinjectors or as combination products. 

IDT Biologika is unique in its ability to accommodate the development, testing and manufacture of products for the world’s leading biopharmaceutical companies. Many human vaccines developed by IDT Biologika, together with international partners, are already in use, fighting infectious diseases such as COVID-19, tuberculosis, AIDS, malaria, cancer, dengue fever  and ebola.

If you chose IDT Biologika, you receive reliable high quality services on product because we have the quality and supply mindset unterlining customer needs for speed to market.